{"code": 0, "data": {"rxform": {"data": [{"drug": "Vyvanse", "drugType": "Brand", "forms": [{"form": "Capsule", "strengths": [{"GPI": "61100025100110", "is_generic": false, "NDC": ["59417010110"], "PackageDescription": "Capsule", "PackageSize": [100], "Quantity": [{"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 7, "display": "7", "priceQuantity": 7}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 10, "display": "10", "priceQuantity": 10}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 14, "display": "14", "priceQuantity": 14}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 15, "display": "15", "priceQuantity": 15}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 30, "display": "30", "priceQuantity": 30, "isDisplayTop": true}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 60, "display": "60", "priceQuantity": 60}], "sortstrength": 10, "strength": "10mg", "priceQuantity": 30, "AutoPackageSelect": true, "Description": "Vyvanse is a medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating. Vyvanse belongs to a class of medications called central nervous system stimulants.\r\n\r\nVyvanse is the brand name of the drug lisdexamfetamine.  Vyvanse, marketed by Shire US Inc., was approved for the treatment of ADHD in 2008. In January 2015, Vyvanse was approved for the treatment of binge eating disorder.\r\n", "DeaClassCode": "CII", "seo_name": "vyvanse"}, {"GPI": "61100025100120", "is_generic": false, "NDC": ["59417010210"], "PackageDescription": "Capsule", "PackageSize": [100], "Quantity": [{"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 7, "display": "7", "priceQuantity": 7}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 10, "display": "10", "priceQuantity": 10}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 14, "display": "14", "priceQuantity": 14}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 15, "display": "15", "priceQuantity": 15}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 30, "display": "30", "priceQuantity": 30, "isDisplayTop": true}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 60, "display": "60", "priceQuantity": 60}], "sortstrength": 20, "strength": "20mg", "priceQuantity": 30, "AutoPackageSelect": true, "Description": "Vyvanse is a medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating. Vyvanse belongs to a class of medications called central nervous system stimulants.\r\n\r\nVyvanse is the brand name of the drug lisdexamfetamine.  Vyvanse, marketed by Shire US Inc., was approved for the treatment of ADHD in 2008. In January 2015, Vyvanse was approved for the treatment of binge eating disorder.\r\n", "DeaClassCode": "CII", "seo_name": "vyvanse"}, {"GPI": "61100025100130", "is_generic": false, "NDC": ["59417010310"], "PackageDescription": "Capsule", "PackageSize": [100], "Quantity": [{"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 7, "display": "7", "priceQuantity": 7}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 10, "display": "10", "priceQuantity": 10}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 15, "display": "15", "priceQuantity": 15}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 28, "display": "28", "priceQuantity": 28}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 30, "display": "30", "priceQuantity": 30, "isDisplayTop": true}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 60, "display": "60", "priceQuantity": 60}], "sortstrength": 30, "strength": "30mg", "priceQuantity": 30, "AutoPackageSelect": true, "Description": "Vyvanse is a medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating. Vyvanse belongs to a class of medications called central nervous system stimulants.\r\n\r\nVyvanse is the brand name of the drug lisdexamfetamine.  Vyvanse, marketed by Shire US Inc., was approved for the treatment of ADHD in 2008. In January 2015, Vyvanse was approved for the treatment of binge eating disorder.\r\n", "DeaClassCode": "CII", "seo_name": "vyvanse"}, {"GPI": "61100025100140", "is_generic": false, "NDC": ["59417010410"], "PackageDescription": "Capsule", "PackageSize": [100], "Quantity": [{"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 7, "display": "7", "priceQuantity": 7}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 10, "display": "10", "priceQuantity": 10}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 15, "display": "15", "priceQuantity": 15}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 28, "display": "28", "priceQuantity": 28}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 30, "display": "30", "priceQuantity": 30, "isDisplayTop": true}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 60, "display": "60", "priceQuantity": 60}], "sortstrength": 40, "strength": "40mg", "priceQuantity": 30, "AutoPackageSelect": true, "Description": "Vyvanse is a medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating. Vyvanse belongs to a class of medications called central nervous system stimulants.\r\n\r\nVyvanse is the brand name of the drug lisdexamfetamine.  Vyvanse, marketed by Shire US Inc., was approved for the treatment of ADHD in 2008. In January 2015, Vyvanse was approved for the treatment of binge eating disorder.\r\n", "DeaClassCode": "CII", "seo_name": "vyvanse"}, {"GPI": "61100025100150", "is_generic": false, "NDC": ["59417010510"], "PackageDescription": "Capsule", "PackageSize": [100], "Quantity": [{"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 5, "display": "5", "priceQuantity": 5}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 7, "display": "7", "priceQuantity": 7}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 10, "display": "10", "priceQuantity": 10}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 15, "display": "15", "priceQuantity": 15}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 30, "display": "30", "priceQuantity": 30, "isDisplayTop": true}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 60, "display": "60", "priceQuantity": 60}], "sortstrength": 50, "strength": "50mg", "priceQuantity": 30, "AutoPackageSelect": true, "Description": "Vyvanse is a medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating. Vyvanse belongs to a class of medications called central nervous system stimulants.\r\n\r\nVyvanse is the brand name of the drug lisdexamfetamine.  Vyvanse, marketed by Shire US Inc., was approved for the treatment of ADHD in 2008. In January 2015, Vyvanse was approved for the treatment of binge eating disorder.\r\n", "DeaClassCode": "CII", "seo_name": "vyvanse"}, {"GPI": "61100025100160", "is_generic": false, "NDC": ["59417010610"], "PackageDescription": "Capsule", "PackageSize": [100], "Quantity": [{"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 7, "display": "7", "priceQuantity": 7}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 10, "display": "10", "priceQuantity": 10}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 15, "display": "15", "priceQuantity": 15}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 30, "display": "30", "priceQuantity": 30, "isDisplayTop": true}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 60, "display": "60", "priceQuantity": 60}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 90, "display": "90", "priceQuantity": 90}], "sortstrength": 60, "strength": "60mg", "priceQuantity": 30, "AutoPackageSelect": true, "Description": "Vyvanse is a medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating. Vyvanse belongs to a class of medications called central nervous system stimulants.\r\n\r\nVyvanse is the brand name of the drug lisdexamfetamine.  Vyvanse, marketed by Shire US Inc., was approved for the treatment of ADHD in 2008. In January 2015, Vyvanse was approved for the treatment of binge eating disorder.\r\n", "DeaClassCode": "CII", "seo_name": "vyvanse"}, {"GPI": "61100025100170", "is_generic": false, "NDC": ["59417010710"], "PackageDescription": "Capsule", "PackageSize": [100], "Quantity": [{"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 7, "display": "7", "priceQuantity": 7}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 10, "display": "10", "priceQuantity": 10}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 15, "display": "15", "priceQuantity": 15}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 30, "display": "30", "priceQuantity": 30, "isDisplayTop": true}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 60, "display": "60", "priceQuantity": 60}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 90, "display": "90", "priceQuantity": 90}], "sortstrength": 70, "strength": "70mg", "priceQuantity": 30, "AutoPackageSelect": true, "Description": "Vyvanse is a medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating. Vyvanse belongs to a class of medications called central nervous system stimulants.\r\n\r\nVyvanse is the brand name of the drug lisdexamfetamine.  Vyvanse, marketed by Shire US Inc., was approved for the treatment of ADHD in 2008. In January 2015, Vyvanse was approved for the treatment of binge eating disorder.\r\n", "DeaClassCode": "CII", "seo_name": "vyvanse", "isDisplayTop": true}], "isDisplayTop": true}, {"form": "Tablet Chewable", "strengths": [{"GPI": "61100025100510", "is_generic": false, "NDC": ["59417011501"], "PackageDescription": "Tablet Chewable", "PackageSize": [100], "Quantity": [{"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 4, "display": "4", "priceQuantity": 4}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 5, "display": "5", "priceQuantity": 5}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 10, "display": "10", "priceQuantity": 10}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 14, "display": "14", "priceQuantity": 14}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 15, "display": "15", "priceQuantity": 15}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 30, "display": "30", "priceQuantity": 30, "isDisplayTop": true}], "sortstrength": 10, "strength": "10mg", "priceQuantity": 30, "AutoPackageSelect": true, "Description": "Vyvanse is a medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating. Vyvanse belongs to a class of medications called central nervous system stimulants.\r\n\r\nVyvanse is the brand name of the drug lisdexamfetamine.  Vyvanse, marketed by Shire US Inc., was approved for the treatment of ADHD in 2008. In January 2015, Vyvanse was approved for the treatment of binge eating disorder.\r\n", "DeaClassCode": "CII", "seo_name": "vyvanse"}, {"GPI": "61100025100520", "is_generic": false, "NDC": ["59417011601"], "PackageDescription": "Tablet Chewable", "PackageSize": [100], "Quantity": [{"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 5, "display": "5", "priceQuantity": 5}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 7, "display": "7", "priceQuantity": 7}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 10, "display": "10", "priceQuantity": 10}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 15, "display": "15", "priceQuantity": 15}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 30, "display": "30", "priceQuantity": 30, "isDisplayTop": true}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 60, "display": "60", "priceQuantity": 60}], "sortstrength": 20, "strength": "20mg", "priceQuantity": 30, "AutoPackageSelect": true, "Description": "Vyvanse is a medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating. Vyvanse belongs to a class of medications called central nervous system stimulants.\r\n\r\nVyvanse is the brand name of the drug lisdexamfetamine.  Vyvanse, marketed by Shire US Inc., was approved for the treatment of ADHD in 2008. In January 2015, Vyvanse was approved for the treatment of binge eating disorder.\r\n", "DeaClassCode": "CII", "seo_name": "vyvanse", "isDisplayTop": true}, {"GPI": "61100025100530", "is_generic": false, "NDC": ["59417011701"], "PackageDescription": "Tablet Chewable", "PackageSize": [100], "Quantity": [{"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 1, "display": "1", "priceQuantity": 1}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 3, "display": "3", "priceQuantity": 3}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 4, "display": "4", "priceQuantity": 4}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 15, "display": "15", "priceQuantity": 15}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 24, "display": "24", "priceQuantity": 24}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 30, "display": "30", "priceQuantity": 30, "isDisplayTop": true}], "sortstrength": 30, "strength": "30mg", "priceQuantity": 30, "AutoPackageSelect": true, "Description": "Vyvanse is a medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating. Vyvanse belongs to a class of medications called central nervous system stimulants.\r\n\r\nVyvanse is the brand name of the drug lisdexamfetamine.  Vyvanse, marketed by Shire US Inc., was approved for the treatment of ADHD in 2008. In January 2015, Vyvanse was approved for the treatment of binge eating disorder.\r\n", "DeaClassCode": "CII", "seo_name": "vyvanse"}, {"GPI": "61100025100540", "is_generic": false, "NDC": ["59417011801"], "PackageDescription": "Tablet Chewable", "PackageSize": [100], "Quantity": [{"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 1, "display": "1", "priceQuantity": 1}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 3, "display": "3", "priceQuantity": 3}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 4, "display": "4", "priceQuantity": 4}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 12, "display": "12", "priceQuantity": 12}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 15, "display": "15", "priceQuantity": 15}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 30, "display": "30", "priceQuantity": 30, "isDisplayTop": true}], "sortstrength": 40, "strength": "40mg", "priceQuantity": 30, "AutoPackageSelect": true, "Description": "Vyvanse is a medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating. Vyvanse belongs to a class of medications called central nervous system stimulants.\r\n\r\nVyvanse is the brand name of the drug lisdexamfetamine.  Vyvanse, marketed by Shire US Inc., was approved for the treatment of ADHD in 2008. In January 2015, Vyvanse was approved for the treatment of binge eating disorder.\r\n", "DeaClassCode": "CII", "seo_name": "vyvanse"}, {"GPI": "61100025100550", "is_generic": false, "NDC": ["59417011901"], "PackageDescription": "Tablet Chewable", "PackageSize": [100], "Quantity": [{"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 10, "display": "10", "priceQuantity": 10}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 14, "display": "14", "priceQuantity": 14}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 30, "display": "30", "priceQuantity": 30, "isDisplayTop": true}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 60, "display": "60", "priceQuantity": 60}], "sortstrength": 50, "strength": "50mg", "priceQuantity": 30, "AutoPackageSelect": true, "Description": "Vyvanse is a medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating. Vyvanse belongs to a class of medications called central nervous system stimulants.\r\n\r\nVyvanse is the brand name of the drug lisdexamfetamine.  Vyvanse, marketed by Shire US Inc., was approved for the treatment of ADHD in 2008. In January 2015, Vyvanse was approved for the treatment of binge eating disorder.\r\n", "DeaClassCode": "CII", "seo_name": "vyvanse"}, {"GPI": "61100025100560", "is_generic": false, "NDC": ["59417012001"], "PackageDescription": "Tablet Chewable", "PackageSize": [100], "Quantity": [{"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 5, "display": "5", "priceQuantity": 5}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 10, "display": "10", "priceQuantity": 10}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 15, "display": "15", "priceQuantity": 15}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 20, "display": "20", "priceQuantity": 20}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 30, "display": "30", "priceQuantity": 30, "isDisplayTop": true}, {"rank": 1, "PackageUnit": "EA", "PackageSize": "100", "value": 90, "display": "90", "priceQuantity": 90}], "sortstrength": 60, "strength": "60mg", "priceQuantity": 30, "AutoPackageSelect": true, "Description": "Vyvanse is a medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating. Vyvanse belongs to a class of medications called central nervous system stimulants.\r\n\r\nVyvanse is the brand name of the drug lisdexamfetamine.  Vyvanse, marketed by Shire US Inc., was approved for the treatment of ADHD in 2008. In January 2015, Vyvanse was approved for the treatment of binge eating disorder.\r\n", "DeaClassCode": "CII", "seo_name": "vyvanse"}]}], "friendlyUrl": "rx/drug-prices/vyvanse", "isDisplayTitle": true, "isDisplayTop": true}], "meta": {"VendorResponseTime": 158, "WebMDResponse": 168}}}, "status": "ok"}